Vimarsana
Biggest News Aggregation in the World

Emcure Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Emcure Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Emcure Pharma Today - Breaking & Trending Today

Samara Capital in talks to invest in botanical ingredients maker - Vimarsana News

Samara Capital in talks to invest in botanical ingredients maker

Homegrown private equity fund Samara Capital is in advanced stages of talks to invest in a natural ingredients supplier that has operations in India and ......

Emcure Pharma to launch IPO in 3 months: Namita Thapar of Shark Tank fame - Vimarsana News

Emcure Pharma to launch IPO in 3 months: Namita Thapar of Shark Tank fame

Shark Tank fame and Executive Director of Emcure Pharmaceuticals, Namita Thapar said at the ET NOW Global Business Summit 2024 on February 10 that the company plans to go public within three months.

Aurobindo Pharma now weighs mega IPO of Eugia Pharma Specialities to raise around Rs 4,500 crore - Vimarsana News

Aurobindo Pharma now weighs mega IPO of Eugia Pharma Specialities to raise around Rs 4,500 crore

In May 2021, in a move to improve operational efficiency, Aurobindo Pharma had approved the transfer of its injectable assets into a subsidiary called Eugia Pharma Specialities Limited for “greater focus, attention and specialization” and also to “augment fund-raise and strategic tie-ups in future through joint ventures etc

Innova Captab IPO Gets Subdued Debut Stocks List With Only 5 Premium - Vimarsana News

Innova Captab IPO Gets Subdued Debut Stocks List With Only 5 Premium

Innova Captab IPO Gets Subdued Debut Stocks List With Only 5 Premium

Emcure Pharma: Bain Capital-backed Emcure Pharma files fresh IPO papers with Sebi - Vimarsana News

Emcure Pharma: Bain Capital-backed Emcure Pharma files fresh IPO papers with Sebi

Those selling shares in the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital.